The combination of four different clinical decision rules and an age-adjusted D-dimer cut-off increases the number of patients in whom acute pulmonary embolism can safely be excluded

2012 ◽  
Vol 107 (01) ◽  
pp. 167-171 ◽  
Author(s):  
Inge Mos ◽  
Renée Douma ◽  
Petra Erkens ◽  
Marc Durian ◽  
Tessa Nizet ◽  
...  

SummaryFour clinical decision rules (CDRs) (Wells score, Revised Geneva Score (RGS), simplified Wells score and simplified RGS) safely exclude pulmonary embolism (PE), when combined with a normal D-dimer test. Recently, an age-adjusted cut-off of the D-dimer (patient’s age x 10 μg/l) safely increased the number of patients above 50 years in whom PE could safely be excluded. We validated the age-adjusted D-dimer test and assessed its performance in combination with the four CDRs in patients with suspected PE. A total of 414 consecutive patients with suspected PE who were older than 50 years were included. The proportion of patients in whom PE could be excluded with an ‘unlikely’ clinical probability combined with a normal age-adjusted D-dimer test was calculated and compared with the proportion using the conventional D-dimer cut-off. We assessed venous thromboembolism (VTE) failure rates during three months follow-up. In patients above 50 years, a normal age-adjusted D-dimer level in combination with an ‘unlikely’ CDR substantially increased the number of patients in whom PE could be safely excluded: from 13–14% to 19–22% in all CDRs similarly. In patients over 70 years, the number of exclusions was nearly four-fold higher, and the original Wells score excluded most patients, with an increase from 6% to 21% combined with the conventional and age-adjusted D-dimer cut-off, respectively. The number of VTE failures was also comparable in all CDRs. In conclusion, irrespective of which CDR is used, the age-adjusted D-dimer substantially increases the number of patients above 50 years in whom PE can be safely excluded.

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 3186-3186
Author(s):  
Inge CM Mos ◽  
Renée A Douma ◽  
Petra MG Erkens ◽  
Tessa AC Nizet ◽  
Marc F Durian ◽  
...  

Abstract Abstract 3186 Background Several clinical decision rules (CDRs) are available for the exclusion of acute pulmonary embolism (PE). This prospective multi-center study compared the safety and clinical utility of four CDRs (Wells rule, revised Geneva score, simplified Wells rule and simplified revised Geneva score) in excluding PE in combination with D-dimer testing. Methods Clinical probability of patients with suspected acute PE was assessed using a computerized based “black box”, which calculated all CDRs and indicated the next diagnostic step. A “PE unlikely” result according to all CDRs in combination with a normal D-dimer result excluded PE, while patients with “PE likely” according to at least one of the CDRs or an abnormal D-dimer result underwent CT-scanning. Patients in whom PE was excluded were followed for three months. Results 807 consecutive patients were included and PE prevalence was 23%. The number of patients categorized as “PE unlikely” ranged from 62% (simplified Wells rule) to 72% (Wells rule). Combined with a normal D-dimer level, the CDRs excluded PE in 22–24% of patients. The total failure rates of the CDR-D-dimer combinations were similar (1 failure, 0.5– 0.6%, upper 95% CI 2.9– 3.1%). Despite 30% of the patients had discordant CDR outcomes, PE was missed in none of the patients with discordant CDRs and a normal D-dimer result. Conclusions All four CDRs show similar safety and clinical utility for exclusion of acute PE in combination with a normal D-dimer level. With this prospective validation, the more straightforward simplified scores are ready for use in clinical practice. Disclosures: No relevant conflicts of interest to declare.


2011 ◽  
Vol 4 (4) ◽  
pp. 99-104
Author(s):  
John H Park ◽  
Cole R Spresser ◽  
Jorge A Valdivia ◽  
Michael J Khadavi ◽  
Saikat Das ◽  
...  

Background. Pulmonary embolism (PE) is clinically suspected in many patients who complain of shortness of breath or chest pain due to its nonspecific nature. The prevalence of PE, however, is low in this population. To assist physicians in diagnostic decision making, several clinical decision rules (CDR) have been developed. The appropriate use of these CDRs has been proven to decrease the need for expensive, time consuming, and invasive diagnostic imaging procedures. In this study, the appropriateness of D-dimer and CT usage was investigated to rule out pulmonary emboli based on the simplified Geneva score. Methods. A retrospective review was performed on 74 patients with a CT scan ordered through a pulmonary embolism (PE) protocol. Using clinical data, the patients were stratified into “unlikely” and “likely” groups for the presence of PE based on the simplification of the revised Geneva score. Scores of 0-2 were graded as “unlikely” and scores of 3 or greater were “likely.” Results. There were 45/74 (60.8%) patients in the “unlikely” group. Of these, 14/45 (31.1%) received a D-dimer; eight were normal and six elevated. Only one patient in the elevated group had evidence of a PE. Of the remaining 31(39.2%) patients in the “unlikely” group that did not receive a D-dimer, only one had a PE. The “likely” group consisted of 29 (39.2%) patients of whom six received a D-dimer. Three patients had a normal D-dimer and three had an elevated level. Neither of these two groups had a PE. Of the remaining 23 (60.8%) in the “likely” group who did not receive a D-dimer, six had a PE. Conclusions. Diagnosing pulmonary emboli using D-dimer levels and CT scans may be aided by clinical decision rules such as the simplified Geneva system. This process may lead to more effective use of medical resources.


Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 2469-2469
Author(s):  
Ynse IGV Tichelaar ◽  
Karina Meijer ◽  
Jan ter Maaten ◽  
Matthijs Oudkerk ◽  
Hanneke C. Kluin-Nelemans ◽  
...  

Abstract Abstract 2469 Poster Board II-446 Background: Use of clinical decision rules have been validated in secondary care setting to safely rule out deep vein thrombosis (DVT) without using compression ultra sound (CUS). Clinical decision rules are now also used in primary care in the Netherlands (Thromb Haemost. 2005;94:200-205, Ann Intern Med. 2009;150:229-35). Because of this referral filter, pre-test probability of diagnosing a DVT in a hospital setting could be enlarged. On the other hand, the negative outcome of a clinical decision rule may still lead to referral as primary care physicians may have an a-priori opinion on the risk for DVT in certain patients, despite a low probability of having the disease given by a clinical decision rule (i.e. Bayes theorem). Whether the excellent negative predictive values (NPV's) of these decision rules are therefore still valid in a hospital setting is doubtful. The aim of this prospective single-center university-hospital based study was to confirm whether pre-test probability of diagnosing DVT in our hospital setting was increased due to the referral pattern of primary physicians, compared to historical data (16-27%; Thromb Haemost. 2004;91:1237-46, N Engl J Med. 2003;349:1227-35). We also evaluated the NPV's of the simplified (J Intern Med. 1998;243:15-23) and revised (N Engl J Med. 2003;349:1227-35) Wells score, with and without D-dimer level. Finally, we analyzed whether CRP levels influenced predictive values of these 2 clinical decision rules. Methods: Between April 2008 and July 2009, consecutive patients suspected of DVT by their primary physician who were referred to our emergency department were included. Clinical data were collected prior to laboratory testing to avoid bias of adjudication of clinical outcome events. CUS was used in all patients to establish or rule out a diagnosis on the same day. Calf vein thrombosis or thrombophlebitis was not considered as DVT. D-dimer levels were measured at presentation with a Tina-Quant assay. Levels > 500 ng/ml were considered positive. CRP levels > 5 mg/L were considered high. For both decision rules, patients with a score of < 2 were considered unlikely and those with a score of ≥ 2 were considered likely to have a DVT. Predictive values were calculated for each score, with and without D-dimer or CRP results, respectively. Results: Of 227 patients, 50% were women and 115 (51%) had DVT; 55% of the thromboses were provoked. The median age at presentation was 54 years. The median duration of symptoms before presentation was 5 days. For the simplified Wells score, the NPV was 87%. Adding a negative D-dimer to the calculation increased the NPV to 96%. In patients considered likely to have a DVT, the positive predictive value (PPV) was 63%, which increased to 71% when a positive D-dimer level was included. Using the revised Wells score (which includes the item of previous DVT), the NPV was 86%, which increased to 95% with a negative D-dimer level. In patients considered likely to have a DVT, the PPV was 58% when not considering D-dimer level and 68% with a positive D-dimer level. Of note, the NPV of a negative D-dimer test alone, without considering the Wells score, was 94%. Addition of CRP level did not result in a better PPV or NPV of the simplified or revised Wells score. Interpretation: According to recent literature, we are the first in 5 years to re-validate the simplified and revised Wells score with a D-dimer test in an emergency department population. We found an absolute 24 to 35% increase in prevalence of DVT in this setting compared to historical data. The increased prevalence in our cohort could be due to the use of clinical decision rules in primary care setting, better awareness of primary care physicians for this serious and common disease, or by being a tertiary care center. Referral bias may, however, not be of great influence as a previous study of ours has shown that 50% of patients referred by their primary physician with clinically suspected venous thrombosis were sent to our hospital and the other 50% to the only other hospital in our region (Ann Intern Med. 2006;145:807-15). Decision making in primary care probably reduced the number of referrals to our hospital substantially. However, the NPV of a low Wells score and a negative D-dimer test, or a negative D-dimer test alone were 95% and 94% respectively. Although these preliminary results should be handled with caution due to small numbers, these NPVs may be too low to safely rule out deep vein thrombosis without CUS. Disclosures: No relevant conflicts of interest to declare.


2017 ◽  
Vol 117 (11) ◽  
pp. 2176-2185 ◽  
Author(s):  
Anne Bass ◽  
Kara Fields ◽  
Rie Goto ◽  
Gregory Turissini ◽  
Shirin Dey ◽  
...  

Background Clinical decision rules (CDRs) for pulmonary embolism (PE) have been validated in outpatients, but their performance in hospitalized patients is not well characterized. Objectives The goal of this systematic literature review was to assess the performance of CDRs for PE in hospitalized patients. Methods We performed a structured literature search using Medline, EMBASE and the Cochrane library for articles published on or before January 18, 2017. Two authors reviewed all titles, abstracts and full texts. We selected prospective studies of symptomatic hospitalized patients in which a CDR was used to estimate the likelihood of PE. The diagnosis of PE had to be confirmed using an accepted reference standard. Data on hospitalized patients were solicited from authors of studies in mixed populations of outpatients and hospitalized patients. Study characteristics, PE prevalence and CDR performance were extracted. The methodological quality of the studies was assessed using the QUADAS instrument. Results Twelve studies encompassing 3,942 hospitalized patients were included. Studies varied in methodology (randomized controlled trials and observational studies) and reference standards used. The pooled sensitivity of the modified Wells rule (cut-off ≤ 4) in hospitalized patients was 72.1% (95% confidence interval [CI], 63.7–79.2) and the pooled specificity was 62.2% (95% CI, 52.6–70.9). The modified Wells rule (cut-off ≤ 4) plus D-dimer testing had a pooled sensitivity 99.7% (95% CI, 96.7–100) and pooled specificity 10.8% (95% CI, 6.7–16.9). The efficiency (proportion of patients stratified into the ‘PE unlikely’ group) was 8.4% (95% CI, 4.1–16.5), and the failure rate (proportion of low likelihood patients who were diagnosed with PE during follow-up) was 0.1% (95% CI, 0–5.3). Conclusion In symptomatic hospitalized patients, use of the Wells rule plus D-dimer to rule out PE is safe, but allows very few patients to forgo imaging.


2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Jacob Ortiz ◽  
Rabia Saeed ◽  
Christopher Little ◽  
Saul Schaefer

Risk assessment for pulmonary embolism (PE) currently relies on physician judgment, clinical decision rules (CDR), and D-dimer testing. There is still controversy regarding the role of D-dimer testing in low or intermediate risk patients. The objective of the study was to define the role of clinical decision rules and D-dimer testing in patients suspected of having a PE. Records of 894 patients referred for computed tomography pulmonary angiography (CTPA) at a University medical center were analyzed. The clinical decision rules overall had an ROC of approximately 0.70, while signs of DVT had the highest ROC (0.80). A low probability CDR coupled with a negative age-adjusted D-dimer largely excluded PE. The negative predictive value (NPV) of an intermediate CDR was 86–89%, while the addition of a negative D-dimer resulted in NPVs of 94%. Thus, in patients suspected of having a PE, a low or intermediate CDR does not exclude PE; however, in patients with an intermediate CDR, a normal age-adjusted D-dimer increases the NPV.


2021 ◽  
Vol 10 (22) ◽  
pp. 5433
Author(s):  
Maribel Quezada-Feijoo ◽  
Mónica Ramos ◽  
Isabel Lozano-Montoya ◽  
Mónica Sarró ◽  
Verónica Cabo Muiños ◽  
...  

Background: Elderly COVID-19 patients have a high risk of pulmonary embolism (PE), but factors that predict PE are unknown in this population. This study assessed the Wells and revised Geneva scoring systems as predictors of PE and their relationships with D-dimer (DD) in this population. Methods: This was a longitudinal, observational study that included patients ≥75 years old with COVID-19 and suspected PE. The performances of the Wells score, revised Geneva score and DD levels were assessed. The combinations of the DD level and the clinical scales were evaluated using positive rules for higher specificity. Results: Among 305 patients included in the OCTA-COVID study cohort, 50 had suspected PE based on computed tomography pulmonary arteriography (CTPA), and the prevalence was 5.6%. The frequencies of PE in the low-, intermediate- and high-probability categories were 5.9%, 88.2% and 5.9% for the Geneva model and 35.3%, 58.8% and 5.9% for the Wells model, respectively. The DD median was higher in the PE group (4.33 mg/L; interquartile range (IQR) 2.40–7.17) than in the no PE group (1.39 mg/L; IQR 1.01–2.75) (p < 0.001). The area under the curve (AUC) for DD was 0.789 (0.652–0.927). After changing the cutoff point for DD to 4.33 mg/L, the specificity increased from 42.5% to 93.9%. Conclusions: The cutoff point DD > 4.33 mg/L has an increased specificity, which can discriminate false positives. The addition of the DD and the clinical probability scales increases the specificity and negative predictive value, which helps to avoid unnecessary invasive tests in this population.


Sign in / Sign up

Export Citation Format

Share Document